Despite tremendous progress in improving cardiovascular outcomes, cardiovascular disease remains the leading cause of death in the US and around the world. Cardiovascular disease and quality of care remain urgent public health issues demanding solutions coupled with agility, speed and data-driven insights to improve outcomes.
Improving outcomes with agility, speed and data-driven insights
As a global leader in cardiovascular drug development (cardiovascular CRO), we work with innovative companies at the forefront of cardiovascular therapies. This includes small to midsize biotech companies who turn to our specialized Cardiovascular team for specialized therapeutic expertise, our therapeutic depth and our flexible, creative approach to meeting your most complex challenges.
Minimizing patient burden, maximizing patient benefit in cardiovascular clinical research
The contributions patients can make to the cardiovascular clinical research enterprise are invaluable. We listen and learn from them to map their journey to inform study goals and reduce the burden of trial participation, using home health, telemedicine and digital technology platforms to facilitate decentralized solutions.
Targeted and proven cardiovascular site network for high performance
With our dedicated focus on cardiovascular disease, we’ve built a global, trusted, network of more than 2,200 sites specializing in cardiovascular studies. These are the high-performing sites you want to work with in order to meet recruitment targets, enroll the right patients, optimize study start-up and ensure operational excellence.
Taking studies to where the patients are
Digital health technologies have the potential to increase efficiency and data capture, while creating exciting new ways to accelerate patient access, improve retention and increase diversity. We combine deep insights, agile technologies, innovative trial design experience and operational excellence to bring clinical trials closer to the patient.